Neuphoria Therapeutics, Inc. (NEUP)
3.89
+0.09
(+2.37%)
USD |
NASDAQ |
Dec 18, 16:00
3.85
-0.04
(-1.03%)
Pre-Market: 08:44
Neuphoria Therapeutics Market Cap: 7.313M for Dec. 18, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Adverum Biotechnologies, Inc. | 96.26M |
| Aditxt, Inc. | 0.6318M |
| Recursion Pharmaceuticals, Inc. | 2.311B |
| X4 Pharmaceuticals, Inc. | 320.02M |
| Inhibrx Biosciences, Inc. | 1.235B |
Market Cap Related Metrics
| PE Ratio | 4.306 |
| PS Ratio | 14.87 |
| Price to Book Value | 0.5846 |
| Price | 3.89 |
| Earnings Yield | 23.23% |
| Normalized PE Ratio | 1.694 |